The Impact of Surgical Experience in VATS Lobectomy on Conversion and Patient Quality of Life: Results from a Comprehensive National Video-Assisted Thoracic Surgical Database.

VATS lobectomy lung cancer quality of life seniority surgical experience

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Jan 2023
Historique:
received: 03 12 2022
revised: 04 01 2023
accepted: 06 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

Although unexpected conversion during Video-Assisted Thoracic Surgery (VATS) lobectomy is up to 23%, the effects on postoperative outcomes remain debatable. This retrospective study aimed: (i) to identify potential preoperative risk factors of VATS conversion to standard thoracotomy; (ii) to assess the impact of surgical experience in VATS lobectomy on conversion rate and patient health-related quality of life. We extracted detailed information on VATS lobectomy procedures performed consecutively (2014-2019). Predictors of conversion were assessed with univariable and multivariable logistic regressions. To assess the impact of VATS lobectomy experience, observations were divided according to surgeons' experiences with VATS lobectomy. The impact of VATS lobectomy experience on conversion and occurrence of postoperative complications was evaluated using logistic regressions. The impact of VATS lobectomy experience on EuroQoL-5D (EQ-5D) scores at discharge was assessed using Tobit regressions. A total of 11,772 patients underwent planned VATS for non-small-cell lung cancer (NSCLC), with 1074 (9.1%) requiring conversion to thoracotomy. The independent predictors at multivariable analysis were: FEV1% (OR = 0.99; 95% CI: 0.98-0.99, Clinical nodal involvement was confirmed as the most critical predictor of conversion. Greater experience in VATS lobectomy did not decrease conversion rate and postoperative complications but was positively associated with postoperative patient quality of life.

Identifiants

pubmed: 36672359
pii: cancers15020410
doi: 10.3390/cancers15020410
pmc: PMC9857299
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : 5 x 1000
Organisme : Ministero della Salute
ID : Ricerca Corrente

Références

Value Health. 2019 Jan;22(1):23-30
pubmed: 30661630
Ann Transl Med. 2019 Jan;7(1):23
pubmed: 30788370
Ann Surg. 2021 Sep 16;:
pubmed: 34534988
Ann Cardiothorac Surg. 2012 May;1(1):47-50
pubmed: 23977465
Interact Cardiovasc Thorac Surg. 2021 Apr 8;32(3):356-363
pubmed: 33221893
Ann Thorac Surg. 2016 Jun;101(6):2077-84
pubmed: 27021033
Surg Endosc. 2016 Jun;30(6):2415-21
pubmed: 26335073
Eur J Surg Oncol. 2019 May;45(5):857-862
pubmed: 30661924
Cancers (Basel). 2022 Feb 28;14(5):
pubmed: 35267572
J Thorac Cardiovasc Surg. 2021 Feb;161(2):403-413.e2
pubmed: 32386762
Lancet Oncol. 2016 Jun;17(6):836-844
pubmed: 27160473
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):490-497
pubmed: 27744321
Eur J Cardiothorac Surg. 2020 Aug 1;58(Suppl_1):i14-i22
pubmed: 32083654
J Thorac Cardiovasc Surg. 2014 May;147(5):1727
pubmed: 24793614
J Thorac Dis. 2019 Mar;11(3):643-645
pubmed: 31019748
Eur J Cardiothorac Surg. 2016 Feb;49(2):602-9
pubmed: 25913824
Ann Thorac Surg. 2016 Mar;101(3):1037-42
pubmed: 26822346
J Thorac Dis. 2018 Mar;10(Suppl 4):S564-S570
pubmed: 29629203
Interact Cardiovasc Thorac Surg. 2021 Jun 28;33(1):68-75
pubmed: 33585859
Ann Thorac Surg. 2022 Aug;114(2):409-417
pubmed: 34921815
J Thorac Dis. 2013 Aug;5 Suppl 3:S182-9
pubmed: 24040521
Ann Thorac Surg. 2020 May;109(5):1522-1529
pubmed: 31981504
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):
pubmed: 28710298
Thorac Surg Clin. 2008 Aug;18(3):275-80
pubmed: 18831503
Ann Oncol. 2014 Aug;25(8):1462-74
pubmed: 24562446
J Thorac Cardiovasc Surg. 2015 Jan;149(1):55-61, 62.e1
pubmed: 25439768
Eur J Cardiothorac Surg. 2020 Jul 1;58(1):70-77
pubmed: 32034907
Eur J Cardiothorac Surg. 2020 Jan 1;57(1):92-99
pubmed: 31157367
Int J Surg. 2019 Dec;72:156-165
pubmed: 31704426
Surgery. 2022 Nov;172(5):1364-1372
pubmed: 36038374
Interact Cardiovasc Thorac Surg. 2021 Jan 1;32(1):55-63
pubmed: 33236089
Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):244-9
pubmed: 23169877
Chest. 2013 May;143(5 Suppl):e278S-e313S
pubmed: 23649443
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
J Thorac Dis. 2021 Feb;13(2):812-823
pubmed: 33717554
J Thorac Dis. 2014 Oct;6(Suppl 6):S637-40
pubmed: 25379202
Ann Thorac Surg. 2016 Aug;102(2):394-9
pubmed: 27344281

Auteurs

Luca Bertolaccini (L)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Giulia Fornaro (G)

Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, 20136 Milan, Italy.

Oriana Ciani (O)

Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, 20136 Milan, Italy.

Elena Prisciandaro (E)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Roberto Crisci (R)

Department of Life, Health and Environmental Sciences, Thoracic Surgery Unit, University of L'Aquila, 64100 Teramo, Italy.

Rosanna Tarricone (R)

Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, 20136 Milan, Italy.

Lorenzo Spaggiari (L)

Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Classifications MeSH